COVID Vaccines/Therapeutics – Developer/Manufacturer Announcements
[Selected press releases/announcements from organizations from WHO EUL/PQ listing above and other organizations]

 

AstraZeneca
Press Releases
AstraZeneca signs licence agreement with RQ Biotechnology for monoclonal antibodies against COVID-19
17 May 2022

 

Bharat Biotech
Press Releases – No new digest announcements identified

BioCubaFarma – Cuba
Últimas Noticias – Website not leading at inquiry

 

Biological E
News
Biological E. Limited Reduces CORBEVAX Price to Rs.250 a Dose
Hyderabad, May 16, 2022:
The reduced price aims at protecting the maximum number of children against the virus
The move comes a few weeks after receiving the EUA for children between the ages of 5 and 12

 

Biontech
Press Releases
Pfizer and BioNTech Granted U.S. Emergency Use Authorization for Booster Dose of Their COVID-19 Vaccine in Children 5 Through 11 Years of Age
16 May 2022
EUA is based on data that show children 5 through 11 years of age had a robust immune response with a favorable safety profile following a 10-µg booster dose of the Pfizer-BioNTech COVID-19 Vaccine at a time when Omicron was the prevalent variant
Children 5 through 11 years of age now authorized to receive a booster dose at least five months after the second dose of the two-dose primary series
To date, 4,500 children 5 through 11 years of age have participated in the companies’ COVID-19 vaccine clinical trial

Pfizer and BioNTech Provide Update on COVID-19 Vaccine Supply Agreement with European Commission
16 May 2022

 

CanSinoBIO
News – Website not responding at inquiry

 

CIGB
Latest News – No new digest announcements identified

 

Cinagen
Recent News
Reports of unauthorized export and availability of counterfeit products of CinnaGen
15 May 2022 [Specific products not identified]

Clover Biopharmaceuticals – China
News – No new digest announcements identified

 

Curevac [Bayer Ag – Germany]
News – No new digest announcements identified

 

Gamaleya National Center
Latest News and Events – See Russia below.

IMBCAMS, China
Home – Website not responding at inquiry

 

Janssen/JNJ
Press Releases – No new digest announcements identified

 

Medicago
Media – No new digest announcements identified

 

Moderna
Press Releases
18 May, 2022
IAVI and Moderna Launch First-in-Africa Clinical Trial of mRNA HIV Vaccine Development Program
Phase I trial in Rwanda and South Africa aims to evaluate mRNA HIV vaccine antigen for safety and immunogenicity and strengthen regional scientific capacity

 

Nanogen
News – No new digest announcements identified

 

Novavax
Press Releases
May 20, 2022
Statement
Novavax Files in the European Union for Expanded Conditional Marketing Authorization of COVID-19 Vaccine as a Booster in Individuals Aged 18 and Over

 

Pfizer
Recent Press Releases
05.17.2022
Pfizer and BioNTech Granted U.S. Emergency Use Authorization for Booster Dose of Their COVID-19 Vaccine in Children 5 Through 11 Years of Age
EUA is based on data that show children 5 through 11 years of age had a robust immune response with a favorable safety profile following a 10-µg booster dose of the Pfizer-BioNTech COVID-19 Vaccine at a time when Omicron was the prevalent variant
Children 5 through 11 years of age now authorized to receive a booster dose at least five months after the second dose of the two-dose primary series
To date, 4,500 children 5 through 11 years of age have participated in the companies’ COVID-19 vaccine clinical trial

 

R-Pharm
https://rpharm-us.com/index.php
[No news or media page identified]

 

Sanofi Pasteur
Press Releases – No new digest announcements identified

 

Serum Institute of India
NEWS & ANNOUNCEMENTS – No new digest announcements identified

Shifa Pharmed [Iran]
http://shafapharmed.com/
No news page identified.

 

Sinopharm/WIBPBIBP
News – No new digest announcements identified

 

Sinovac
Press Releases – No new digest announcements identified

 

Vector State Research Centre of Viralogy and Biotechnology
Home – No new digest announcements identified [404 error]

 

WestVac Biopharma
Media – No new digest announcements identified

Zhifei Longcom, China
[Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.]
[No website identified]

 

::::::

GSK
Press releases for media – No new digest announcements identified

 

Merck
News releases – No new digest announcements identified

 

Novartis
News – No new digest announcements identified

 

SK Biosciences
Press Releases
SK bioscience and the Bill & Melinda Gates Foundation Agreed to Strengthen Partnership
2022.05.17

 

Valneva
Press Releases
May 19, 2022
EMA accepts filing of marketing authorization application for Valneva’s inactivated COVID-19 Vaccine Candidate

May 16, 2022
Valneva Receives Notice of European Commission’s Intent to Terminate COVID-19 Vaccine Purchase Agreement – Webcast Link

May 16, 2022
Valneva Receives Emergency Use Authorization from the United Arab Emirates for its Inactivated COVID-19 Vaccine